Primary |
Depression |
41.1% |
Product Used For Unknown Indication |
23.7% |
Anxiety |
6.5% |
Major Depression |
4.5% |
Hypertension |
3.1% |
Bipolar Disorder |
2.7% |
Pain |
2.5% |
Drug Use For Unknown Indication |
2.2% |
Insomnia |
2.0% |
Sleep Disorder |
1.6% |
Schizophrenia |
1.3% |
Post-traumatic Stress Disorder |
1.2% |
Migraine |
1.1% |
Prophylaxis Of Neural Tube Defect |
1.1% |
Convulsion |
1.0% |
Epilepsy |
1.0% |
Back Pain |
0.9% |
Hypercholesterolaemia |
0.9% |
Obsessive-compulsive Disorder |
0.9% |
Psychotic Disorder |
0.9% |
|
Drug Ineffective |
13.1% |
Completed Suicide |
10.6% |
Vomiting |
9.4% |
Serotonin Syndrome |
7.8% |
Toxicity To Various Agents |
7.8% |
Death |
6.1% |
Drug Abuse |
4.9% |
Withdrawal Syndrome |
4.5% |
Tachycardia |
4.1% |
Suicidal Ideation |
3.7% |
Suicide Attempt |
3.7% |
Drug Exposure During Pregnancy |
2.9% |
Premature Baby |
2.9% |
Respiratory Arrest |
2.9% |
Somnolence |
2.9% |
Tremor |
2.9% |
Weight Increased |
2.9% |
Drug Interaction |
2.4% |
Intentional Overdose |
2.4% |
Malaise |
2.4% |
|
Secondary |
Product Used For Unknown Indication |
34.0% |
Depression |
26.9% |
Drug Use For Unknown Indication |
9.3% |
Anxiety |
6.7% |
Major Depression |
3.3% |
Hypertension |
3.1% |
Sleep Disorder |
3.1% |
Pain |
2.6% |
Bipolar I Disorder |
1.9% |
Panic Disorder |
1.6% |
Bipolar Disorder |
0.9% |
Gastrooesophageal Reflux Disease |
0.8% |
Resuscitation |
0.8% |
Schizophrenia |
0.8% |
Hypothyroidism |
0.7% |
Prophylaxis Of Neural Tube Defect |
0.7% |
Psychotic Disorder |
0.7% |
Arthritis |
0.7% |
Delirium |
0.7% |
Ill-defined Disorder |
0.7% |
|
Completed Suicide |
12.5% |
Weight Increased |
10.6% |
Vomiting |
8.1% |
Toxicity To Various Agents |
6.5% |
Overdose |
6.2% |
Drug Ineffective |
5.6% |
Withdrawal Syndrome |
5.6% |
Hyponatraemia |
5.3% |
Suicide Attempt |
5.0% |
Vision Blurred |
5.0% |
Ataxia |
3.7% |
Serotonin Syndrome |
3.7% |
Drug Abuse |
3.1% |
Suicidal Ideation |
3.1% |
Drug Toxicity |
2.8% |
Paraesthesia |
2.8% |
Tachycardia |
2.8% |
Drug Interaction |
2.5% |
Liver Function Test Abnormal |
2.5% |
Somnolence |
2.5% |
|
Concomitant |
Prophylaxis |
17.7% |
Depression |
12.7% |
Drug Use For Unknown Indication |
11.5% |
Product Used For Unknown Indication |
9.6% |
Dehydration |
5.6% |
Cough |
5.5% |
Hypertension |
4.5% |
Fluid Replacement |
4.4% |
Medication Dilution |
4.4% |
Rheumatoid Arthritis |
3.8% |
Pain |
3.7% |
Chemotherapy |
2.7% |
Constipation |
2.7% |
Therapeutic Procedure |
1.9% |
Anxiety |
1.7% |
Hiv Infection |
1.7% |
Diabetes Mellitus |
1.6% |
Breast Cancer |
1.6% |
Mineral Supplementation |
1.4% |
Crohn's Disease |
1.4% |
|
Weight Increased |
13.6% |
Vomiting |
12.1% |
Pulmonary Embolism |
8.7% |
Weight Decreased |
7.2% |
Drug Ineffective |
6.8% |
Somnolence |
4.2% |
Urinary Tract Infection |
4.2% |
White Blood Cell Count Decreased |
4.2% |
Pain |
3.8% |
Suicide Attempt |
3.8% |
International Normalised Ratio Increased |
3.4% |
Nausea |
3.4% |
Tremor |
3.4% |
Vitreous Floaters |
3.4% |
White Blood Cell Count Increased |
3.4% |
Drug Interaction |
3.0% |
Lung Neoplasm Malignant |
3.0% |
Overdose |
3.0% |
Urticaria |
3.0% |
Headache |
2.6% |
|
Interacting |
Depression |
22.1% |
Diabetes Mellitus |
10.4% |
Product Used For Unknown Indication |
8.4% |
Drug Use For Unknown Indication |
7.8% |
Bipolar Disorder |
7.1% |
Major Depression |
7.1% |
Back Pain |
5.8% |
Tachyarrhythmia |
5.2% |
Blood Cholesterol Increased |
2.6% |
Cystitis |
2.6% |
Drug Exposure During Pregnancy |
2.6% |
Dyslipidaemia |
2.6% |
High Density Lipoprotein Decreased |
2.6% |
Anxiety |
1.9% |
Dysthymic Disorder |
1.9% |
Epilepsy |
1.9% |
Hepatitis C |
1.9% |
Smoking Cessation Therapy |
1.9% |
Type 1 Diabetes Mellitus |
1.9% |
Asthenia |
1.3% |
|
Drug Interaction |
17.5% |
Urinary Retention |
12.5% |
Myocardial Infarction |
10.0% |
Serotonin Syndrome |
10.0% |
Toxicity To Various Agents |
10.0% |
Tremor |
10.0% |
Hyperhidrosis |
5.0% |
Withdrawal Syndrome |
5.0% |
Accidental Overdose |
2.5% |
Hypoplastic Right Heart Syndrome |
2.5% |
Medication Error |
2.5% |
Neuroleptic Malignant Syndrome |
2.5% |
Neutropenia |
2.5% |
Therapeutic Response Decreased |
2.5% |
Urinary Tract Infection |
2.5% |
Weight Decreased |
2.5% |
|